Navigation Links
Covaris Receives the Society for Laboratory Automation and Screening (SLAS) New Product Award at LabAutomation 2011
Date:2/9/2011

WOBURN, Mass., Feb. 9, 2011 /PRNewswire/ -- The Covaris® LE220™ high performance ultra-sonicator has received the prestigious SLAS New Product Award at the LabAutomation 2011 conference in Palm Springs CA.  With over 4,400 attendees, LabAuto is the premier laboratory automation conference and exhibition, bringing science, technology, and industry together.

Breakthrough products introduced at LabAutomation are evaluated by a team of industry experts.  Each year, the best and most promising new products are recognized with the SLAS New Product Award.  Covaris is very pleased to announce that for 2011, the LE220 is a recipient of the New Product Award designation.  

The LE220 was chosen for the New Product Award from more than 400 LabAutomation 2011 exhibitors, based on its technical originality, anticipated impact on the field of laboratory automation, supporting data that reflects universal scientific methodology, and market demand.  According to Jim Laugharn, Founder and CEO, "The NPA award is significant recognition and is an affirmation that the patented, controlled AFA physicochemical process is indeed a unique technology platform.  This award also reflects the increasing importance of sample preparation as a fundamental component of advanced life science systems, such as in Next Generation DNA Sequencing."

The LE220 Ultra-sonicator

The LE220 is specifically designed for high-throughput, parallel-processing operations utilizing the Covaris Adaptive Focused Acoustic™ (AFA™) technology.  The LE220 is ideal for next-gen nucleic acid sequencing, compound dissolution, tissue/cell lysis applications, and other high-throughput applications.  With DNA shearing performance characteristics matching industry-standard Covaris S-series and E-series instruments, the LE220 reproducibly shears DNA to desired lengths, in a multi-sample parallel-processing mode. &#
'/>"/>

SOURCE Covaris, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July, 29  2014 ISPE—the International Society ... John Bournas as President and CEO, ... to leave the Society last fall.  Mr. Bournas ... in the healthcare association industry as well as ... a clear vision for the expansion of its ...
(Date:7/29/2014)... , July 29, 2014 McGraw-Hill Education ... for the science, technical, and medical communities, has announced ... first off-line mobile application of the world-renowned medical education ... new AccessMedicine App , available for download onto ... now be able to gain access to valuable ...
(Date:7/29/2014)... , July 29, 2014  Instrumentation Laboratory (IL) today announced ... new corporate logo. This is part of a comprehensive rebranding ... Founded in Boston, MA , in 1959, ... companies since 1992.  Other companies in the group include Inova ... Systelab ( Barcelona, Spain ).  Like IL, these ...
Breaking Medicine Technology:ISPE Hires Healthcare Association Exec as CEO 2ISPE Hires Healthcare Association Exec as CEO 3McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 2McGraw-Hill Education Professional's AccessMedicine App Delivers Instant Access to Essential Diagnostic Tools 3Instrumentation Laboratory Unveils New Corporate Brand 2Instrumentation Laboratory Unveils New Corporate Brand 3
... , ... the Medical University of South Carolina (MUSC) are the first ... of detecting cardiac disease using enhanced computed tomography scanning technology.  The ... of the Journal of Cardiovascular Computed Tomography. , CT ...
... DIEGO , Feb. 10 Amira Pharmaceuticals, Inc. ... and Flavia V. Castelino , M.D. of Massachusetts General ... proof-of-concept study which demonstrates that the bioactive lipid lysophosphatidic acid ... mediator of fibrogenesis in the bleomycin mouse model of scleroderma. ...
Cached Medicine Technology:Medical University of South Carolina First To Test New Heart Imaging Method To Detect Coronary Artery Disease 2Medical University of South Carolina First To Test New Heart Imaging Method To Detect Coronary Artery Disease 3Medical University of South Carolina First To Test New Heart Imaging Method To Detect Coronary Artery Disease 4Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma 2
(Date:7/29/2014)... (PRWEB) July 29, 2014 Parker Waichman ... rights of victims injured by defective drugs and medical ... filed by plaintiffs in Canada who allege that they ... events with the low testosterone injection Delatestryl (Court ... 22, 2014 in the Ontario Superior Court of Justice. ...
(Date:7/29/2014)... Colorado (PRWEB) July 29, 2014 Daily Gossip ... a powerful and holistic system that will teach users how ... tried by thousands of people, from all over the world. ... the symptoms of this disorder in as quickly as 12 ... be gone faster than imagined. , The Fibroids Miracle ...
(Date:7/29/2014)... Daily Gossip indicates in its Natural Vitiligo ... by a popular nutritionist and health specialist. Michael Dawson ... this disorder, but none of them worked. , According ... having to look for an alternative vitiligo treatment, which ... method, too, to become vitiligo free. , To ...
(Date:7/29/2014)... July 29, 2014 (HealthDay News) --,The time at which ... their chances for survival, new research suggests. Showing ... or during holidays is associated with a 13 percent ... hours, researchers report. Every year, more than 250,000 ... severe type of heart attack, which is caused by ...
(Date:7/29/2014)... Randy Dotinga HealthDay Reporter ... When most children take on a task, various brain ... neuro-boosting activity in kids with autism, according to a ... symptoms of autism displayed even less of this "brain ... flexibility often causes difficulty when children with autism are ...
Breaking Medicine News(10 mins):Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 2Health News:Class Action Lawsuit in Canada Alleges Manufacturer of Delatestryl Testosterone Injection Failed to Warn of Cardiovascular Risks, Parker Waichman LLP Reports 3Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2Health News:Natural Vitiligo Treatment System Review Reveals Michael Dawson’s New Vitiligo Cure Program 2Health News:Heart Attack Patients Treated at Night, Weekends May Have Worse Outcomes 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 2Health News:Less Flexibility Seen in Brain Wiring of Kids With Autism: Study 3
... study accepted for publication in The Endocrine Society,s ... demonstrated a novel and accurate test for early diagnosis ... to 2,000 female live births and early diagnosis allows ... conditions including cardiac and renal problems. Turner syndrome ...
... , TUESDAY, Dec. 7 (HealthDay News) -- Electronic cigarettes ... University of California researchers say. Their study ... devices that contain nicotine, flavorings and other chemicals. The ... and Drug Administration cited five e-cigarette distributors for poor ...
... Summit and Left Main Coronary Interventions Course is ... and new developments in therapeutic procedures essential for ... coronary occlusions and left main coronary interventions. Topics ... and why to open a chronic total occlusion ...
... 7 (HealthDay News) -- The presence of a certain biomarker ... increased risk of death from all causes, a new study ... T (cTnT) -- a heart-specific protein that serves as ... cTnT levels are associated with a number of chronic diseases ...
... TUESDAY, Dec. 7 (HealthDay News) -- Teens who are allowed ... smoking than teens whose parents bar them from viewing mature ... the study authors estimated that if 10- to 14-year-olds were ... to smoke could drop two to threefold. , However, ...
... Dec. 7 (HealthDay News) -- Teens who have health problems ... friendships are stronger than they actually are, new research shows. ... took part in a 1994-1996 survey that asked them about ... teens rated their health as "excellent" or "very good." The ...
Cached Medicine News:Health News:E-Cigarettes Should Be Banned Until Made Safe: Study 2Health News:CTO Summit & Left Main Coronary Interventions Course to be held Feb. 14-16, 2011, in NYC 2Health News:New Test Links Blood Protein to Heart Disease, Diabetes Risk 2Health News:Watching R-rated Movies Ups Odds of Teens Smoking 2Health News:Watching R-rated Movies Ups Odds of Teens Smoking 3Health News:Teens' Poor Health Linked to Fewer Friends 2
... Advia 2400 has minimal ... (as low as 2 ... (40 L/hour) thus maximizing ... universal rack handler facilitates ...
Iron Total (TIBC) (Iron Buffer + Iron Color=Std.). An Automated analyzer test kits....
... For determination of HDL-cholesterol ... Hitachi 717. Specific immunochemical inhibition ... established reference methods. Endpoint assay. ... stable, ready-to-use reagent. Available with ...
Cholesterol/HDL with 200 tests....
Medicine Products: